A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function
Clinical trial NCT01513083 · COMPLETED
Trial details
- NCT number
- NCT01513083
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-09-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.